Angela M. Davies

Temple College — United States

Medicine · Health Sciences

41h-index7.5kcitations184works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(59), Lung Cancer Research Studies(35), Colorectal Cancer Treatments and Studies(24), Peptidase Inhibition and Analysis(19), Cancer Genomics and Diagnostics(17)

Publications170 total

Enhanced oxygen availability and preserved aggregative function in platelet concentrates stored at reduced platelet concentration
Transfusion·2024· 2 citedOpen Access
3D Printing Based on Material Extrusion to Create Surface Patterns on Textile Fabrics
Fibers and Polymers·2023· 1 cited
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation
Transfusion Medicine·2023· 20 cited
Alun Owen Davies
BMJ·2022
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML
In Vivo·2022· 9 citedOpen Access
Abstract 1112: Feasibility of real-time personalized patient-derived Tumorgraft® models for guiding systemic treatment in recurrent and/or metastatic head and neck cancer patients
Cancer Research·2020· 1 cited
Abstract 1923: KRAS-mutant (mt) colorectal cancer (CRC) organoid models generated from patient-derived xenografts (PDX) show response to combination of trametinib (Tm), neratinib (N), and trastuzumab (Tz)
Tumor Biology·2019Open Access
Abstract 1923: KRAS-mutant (mt) colorectal cancer (CRC) organoid models generated from patient-derived xenografts (PDX) show response to combination of trametinib (Tm), neratinib (N), and trastuzumab (Tz)
Cancer Research·2019· 2 cited
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Skeletal Muscle·2019· 24 citedOpen Access
The HDAC3–SMARCA4–miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma
Science Signaling·2018· 82 cited
Abstract 1150: Acute myeloid leukemia human/mouse co-clinical trial feasibility study optimized in human transgenic IL-3/GMCSF NOD/Shi-<i>scid</i>-IL2rγ<i>null</i> mice
Cancer Research·2018
Abstract LB-087: Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status
Cancer Research·2018
Abstract A43: Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities
Cancer Research·2018
Abstract A018: Patient-derived xenograft (PDX) models of NSCLC reflect clinical drug responses and predict effective treatments for patients
Molecular Cancer Therapeutics·2018
Abstract A016: NOG-EXL mice have superior immune cell engraftment and lineage development in the human immune system (HIS) model, the ImmunoGraft
Molecular Cancer Therapeutics·2018· 1 cited
Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial
Lung Cancer·2018· 4 cited
Healthcare textiles
Elsevier eBooks·2017· 10 citedOpen Access
Contributors
Elsevier eBooks·2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Nature Medicine·2017· 642 citedOpen Access
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
2017
page 1 of 9Next →

Frequent Co-authors

David R. Gandara(27), Primo N. Lara(22), Philip C. Mack(16), Paul H. Gumerlock(14), Derick Lau(11), Kari Chansky(6), Laurel Beckett(5), Wilbur A. Franklin(4), John J. Crowley(4), Cheryl Ho(3), William K. Evans(3), Kathy S. Albain(3), William Holland(3), Richard J. Bold(3), Howard West(3), Fred R. Hirsch(3), Stephen Shibata(3), David P. Schenkein(3), Harvey I. Pass(2), Ning Qiao(2)